Article Details

Here's Why You Should Add Immunovant (IMVT) to Your Portfolio - Yahoo Finance

Retrieved on: 2024-04-22 18:17:39

Tags for this article:

Click the tags to see associated articles and topics

Here's Why You Should Add Immunovant (IMVT) to Your Portfolio - Yahoo Finance. View article details on hiswai:

Excerpt

IMVT is a New York-based biopharmaceutical company, which develops monoclonal antibodies for the treatment of autoimmune diseases. The company ...

Article found on: finance.yahoo.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo